Mefloquine : List of nationally authorised medicinal products - PSUSA/00001955/202302
Mefloquine : List of nationally authorised medicinal products - PSUSA/00001955/202302
Mefloquine : List of nationally authorised medicinal products - PSUSA/00001955/202302
Saccharomyces boulardii : List of nationally authorised medicinal products - PSUSA/00009284/202302
Haemophilus type b conjugate vaccines : List of nationally authorised medicinal products - PSUSA/00001584/202302
Ipratropium / salbutamol : List of nationally authorised medicinal products - PSUSA/00001781/202301
Ipratropium : List of nationally authorised medicinal products - PSUSA/00001780/202301
Sodium citrate (extracorporeal use) : List of nationally authorised medicinal products - PSUSA/00010986/202301
Influenza vaccine (split virion, inactivated) (non centrally authorised products) : List of nationally authorised medicinal products - PSUSA/00010298/202303
Haemophilus type b and meningococcal group C conjugate vaccine : List of nationally authorised medicinal products - PSUSA/00001583/202302
Influenza vaccine (surface antigen, inactivated) : List of nationally authorised medicinal products - PSUSA/00001744/202303
Opinion/decision on a Paediatric investigation plan (PIP): Ex vivo expanded autologous human keratinocytes containing epidermal stem cells genetically modified with a gamma-retroviral (RV) vector expressing the full-length LAMB3 cDNA (Hologene 5), decision type: , therapeutic area: , PIP number: P/0375/2022